ArticleBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2019

Assessment of the Molecular Mechanism of Action of SB3, a Trastuzumab Biosimilar.

Kyungyeol Paek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.